10.98 0.58 (5.58%) | 11-15 00:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 12.83 | 1-year : | 14.99 |
Resists | First : | 10.98 | Second : | 12.83 |
Pivot price | 10.97 | |||
Supports | First : | 10.44 | Second : | 10.1 |
MAs | MA(5) : | 10.97 | MA(20) : | 10.97 |
MA(100) : | 10.35 | MA(250) : | 10.28 | |
MACD | MACD : | 0.04 | Signal : | 0.06 |
%K %D | K(14,3) : | 98.86 | D(3) : | 98.86 |
RSI | RSI(14): 92.72 | |||
52-week | High : | 11.86 | Low : | 9.8 |
If tomorrow: | Open lower | Open higher |
High: | - | - |
Low: | - | - |
Close: | - | - |
DFP Healthcare Acquisitions Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization or other similar business combination. The company was founded in 2019 and is based in New York, New York.
Fri, 29 Oct 2021
October SPAC Issuance nears $10B and SPACs are Hot Again - TheStreet
Mon, 28 Jun 2021
DFP Healthcare Acquisitions Corp. Announces Proposed Business Combination With The Oncology Institute - Business Wire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NYSE
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 1.#INF |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |